SANDRA FLORES: Open Payments
NPI 1649602145 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,383 in 41 payments from 10 companies in 2025. Trend: 2023 $2,084 · 2024 $1,576 · 2025 $1,383
Food & beverage: $1,383
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $491 |
| Corcept Therapeutics | 9 | $319 |
| AstraZeneca Pharmaceuticals LP | 5 | $291 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $76 |
| Lilly USA, LLC | 2 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $26 |
| Philips North America LLC | 1 | $16 |
Products named: Korlym, Wegovy, Ozempic, FARXIGA, AIRSUPRA, JARDIANCE, MOUNJARO, Kerendia.
Industry payments across TX — which companies pay providers there.
